Medical device marketing that leads with evidence.
Your device works, and the data holds up. Adoption still stalls, because the clinicians, committees, and investors who decide your future have never met the founder and cannot find the evidence on their own. D3 Digital Media installs the operating system that puts your clinical credibility in front of every buyer who vets you, without a single claim going out unreviewed.
Book a Strategy Call See how WAVES worksIn medical devices, adoption is won on evidence long before it is won on reach.
A founder-led device company usually has the hard part solved: a device that performs, a clearance pathway understood, and early clinical data that stands up to scrutiny. What it rarely has is a repeatable way to make that evidence visible to the several distinct buyers who each have to say yes. A clinician champion weighs whether the device fits the way they practice. A hospital's procurement and value-analysis committee weighs cost, risk, and comparative evidence. An investor weighs the same data through the lens of a market. Every one of them starts from the same question: what is the evidence, and can I trust the people behind it?
Right now that question gets answered by the founder, in the room, one account and one conversation at a time. It is the most credible channel you own and the least scalable. It goes quiet the moment the founder is in a design freeze, a regulatory submission, or a raise. Meanwhile the champions and committee members you never met are searching, reading published studies, and increasingly asking an AI assistant to summarize your device, and they land on a thin site that carries none of the evidence the founder carries in person.
Most founder-led device companies do not have a demand problem. They have an evidence-visibility problem that only looks like a demand problem.
Two kinds of help, both wrong for a device company.
Agencies that misread the evidence bar
They chase impressions and write claims that outrun what your data and your clearance actually support. In a regulated field that is not just weak marketing, it is a liability that can put a clearance at risk and lose a clinician's trust in one line. You end up rewriting everything they hand back, and the credible buyers quietly disengage.
Consultants who advise but never build
They understand the adoption path and hand you a positioning deck. Then the site, the evidence library, the search presence, and the cadence all land back on a team already committed to the device and the submission. Nothing gets built, and the deck ages in a drive while the launch window narrows.
A device company needs a third option: a system that respects the regulatory and evidence bar, leads with what the data actually supports, keeps final approval on every claim with your team, and actually gets built and run. That is what WAVES is.
The WAVES operating system, tuned for device adoption.
WAVES is five capabilities that compound into one loop. Each is adapted to how a device actually gets vetted by clinicians, procurement, and investors, and you choose how much you run yourself with Coaching, or have our team run for you with WAVES Managed.
Web Presence
The site and evidence footprint a clinician, a value-analysis committee, or an investor hits while vetting your device, built to answer their real questions and structured so AI tools cite your clinical evidence accurately instead of guessing.
Authority
Search optimization and third-party visibility, from guest platforms to podcasts, that put your clinical evidence in front of champions and committees early, before the first sales conversation rather than after it.
Voice
A captured voice profile for the founder and every spokesperson, so everything sounds like your team and stays inside the claims your data and your clearance actually support.
Engagement
A daily rhythm that surfaces the accounts, clinician champions, and investors signalling intent, so scarce outreach lands on the few relationships that move adoption.
Systems
A shared calendar, a CRM, a weekly scoreboard, and an approval workflow with your compliance sign-off built into the step before anything publishes.
A launch or a repositioning does not fail for lack of effort. It fails because the credibility layer was never installed. The 90-day Onboarding Sprint installs that layer first, so the launch has something to stand on.
One conversation becomes a month of credible, evidence-led visibility.
The engine is built so the founder's scarcest resource, time and judgment, produces the most output for the least effort. Here is the loop.
We capture the thinking
A recorded interview with the founder or a designated clinical or engineering expert. This is the only real time ask, usually a few hours a month, and it is the raw material for everything downstream.
We turn it into assets
Each conversation becomes a long-form article written for search and AI answers, short clips, posts, and, where it fits, a full episode. Evidence-led, tied to what the data supports, never overstated.
Your team approves
Nothing publishes without your compliance sign-off. The approval step is built into the workflow, not bolted on after a claim slips through and puts a clearance at risk.
It compounds
Published evidence keeps ranking and keeps getting found by champions and committees. The weekly scoreboard shows what is landing, and the quarterly checkup resets the plan.
An owned system, not a retainer you rent.
- A search-ready web presence that answers what clinicians, procurement, and investors actually look for when they vet a device.
- A captured voice profile for the founder and spokespeople, so the evidence sounds like your team and stays inside supportable claims.
- A steady stream of evidence-led content, published to your site and structured so AI tools cite your clinical data correctly.
- An approval workflow with your compliance sign-off in the loop before anything goes live.
- A CRM and a weekly scoreboard, so account momentum, visibility, and pipeline are measured, not assumed.
- A quarterly checkup that resets priorities against what actually moved adoption.
Founder-led device and diagnostics-adjacent companies, revenue or pre-revenue.
The fit is a company where one leader still owns the decision and is willing to be in the strategic conversation, where the device works and the evidence is real, and where visibility with clinicians, procurement, or investors is the constraint on the next stage: a launch, a repositioning, or a push to scale. Companies with revenue, usually in the one to fifty million dollar range, tend to run this as Coaching. Clinical-stage and funded pre-revenue companies usually run it as WAVES Managed, because they need visibility with investors, partners, and early adopters before they have the internal team to build it.
If you are still validating the device or still searching for your first indication, that is a different job, and we will say so on the call rather than sell you a system you are not ready to run.
The honest answers.
How is marketing a medical device different from marketing anything else?
Adoption depends on evidence and on convincing several distinct buyers, a clinician champion, a procurement or value-analysis committee, and often an investor, who each weigh the same data differently. WAVES is built to make your clinical evidence visible and credible to all of them, not to chase generic reach that none of them respond to.
Can you support a launch or a repositioning?
Yes, and that is the most common reason companies come to us. The 90-day Onboarding Sprint installs the credibility layer a launch needs first, the web presence, the evidence library, the voice, and the approval workflow, so the launch or the repositioning has a foundation instead of starting from a thin site and the founder's calendar.
How do you keep marketing inside our regulatory and compliance bar?
Your team keeps final approval on every claim and asset, and that approval step is built into the workflow before anything publishes. We lead with evidence and a documented voice, so the message stays inside what your data and your clearance support. Compliance stays with you, by design, because a sloppy claim can put a clearance at risk.
We are pre-revenue and still clinical-stage. Is marketing worth it yet?
Often yes, on WAVES Managed. Clinical-stage and funded device companies frequently need visibility with investors, partners, and early adopters before there is revenue, and that is exactly what Managed is built for: making your evidence and your team visible to the people who fund, partner with, and first adopt the device.
How much of the founder's time does this take?
On WAVES Managed, usually a few hours a month on camera for interviews, plus someone on your team to approve content each week. We handle production, publishing, and the systems. On Coaching, you build it with weekly guidance.
What does it cost?
Coaching starts with a 997 dollar Onboarding Sprint billed with your first month, so month one is 1,694 dollars, then 697 dollars a month. WAVES Managed is scoped to your company, typically from 7,500 dollars a month, and starts with a 90-day pilot. We scope it on a strategy call.
See what evidence-led visibility would do for your adoption curve.
A working conversation, no pitch deck, no upsell. We will map where your credibility is leaking across clinicians, committees, and investors, and what the operating layer would change, specific to your device.
Book a Strategy Call Life sciences marketing →